Clinical Trials
15 trialsNCT03840928 2023-12-13
PatientSpot Formerly Known as ArthritisPower
Global Healthy Living Foundation
Unknown
NCT05588206 2022-10-20
Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer
First People's Hospital of Hangzhou
Phase 1/2 Unknown
NCT05326425 2022-04-20
Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.
Seoul St. Mary's Hospital
Phase 2 Unknown
NCT04291092 2021-09-10
Camrelizumab Combined With Local Treatment in NSCLC Patients With BM
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT02736513 2021-09-02
Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases
Soroka University Medical Center
Phase 2 Unknown
NCT04864821 2021-05-06
Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT04833205 2021-04-20
Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer
Hebei Medical University
Phase 2 Unknown
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT03638206 2019-12-11
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
Phase 1/2 Unknown
NCT04001725 2019-11-13
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT02607605 2017-10-26
ctDNA
Sun Yat-sen University
Unknown
NCT01782287 2017-10-12
Proteome-based Immunotherapy of Lung Cancer Brain Metastases
NeuroVita Clinic
Phase 2/3 Unknown
NCT03257735 2017-08-22
A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases
Sun Yat-sen University
Unknown
NCT02457650 2016-08-03
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
Shenzhen Second People's Hospital
Phase 1 Unknown
NCT00040560 2005-06-24
Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer
Copharos
Phase 1 Unknown